Arkadios Wealth Advisors Abb Vie Inc. Transaction History

Arkadios Wealth Advisors

$1.71 Billion
Q4 2024

A detailed history of Arkadios Wealth Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Arkadios Wealth Advisors holds 33,866 shares of ABBV stock, worth $6.55 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

33,866

Previous 33,975 0.32%

Holding current value

$6.55 Million

Previous $6.71 Million 10.31%

% of portfolio

0.35%

Previous 0.41%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$164.99 - $203.87 $17,983 - $22,221	-109 Reduced 0.32%	33,866 $6.02 Million
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $546,242 - $664,566	3,334 Added 10.88%	33,975 $6.71 Million
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $482,944 - $563,971	3,120 Added 11.34%	30,641 $5.26 Million
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $80,549 - $91,778	-504 Reduced 1.8%	27,521 $5.01 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $866,192 - $975,536	-6,295 Reduced 18.34%	28,025 $4.34 Million
Q3 2023 Oct 13, 2023	BUY	$133.59 - $154.65 $1.3 Million - $1.5 Million	9,715 Added 39.48%	34,320 $5.12 Million
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $227,917 - $283,628	-1,720 Reduced 6.53%	24,605 $3.32 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $251,332 - $289,446	1,738 Added 7.07%	26,325 $4.2 Million
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $508,842 - $610,235	3,679 Added 17.6%	24,587 $0
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $1.28 Million - $1.47 Million	-9,535 Reduced 31.32%	20,908 $2.81 Million
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $376,803 - $479,040	2,738 Added 9.88%	30,443 $4.66 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $678,641 - $842,002	5,142 Added 22.79%	27,705 $4.49 Million
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $263,203 - $333,028	2,450 Added 12.18%	22,563 $3.06 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $154,812 - $175,734	1,455 Added 7.8%	20,113 $2.17 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $1.3 Million - $1.45 Million	12,343 Added 195.46%	18,658 $2.1 Million
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $78,157 - $86,041	764 Added 13.76%	6,315 $683,000
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $267,629 - $361,327	3,325 Added 149.37%	5,551 $594,000
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $42,009 - $49,305	489 Added 28.15%	2,226 $192 Million
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $11,812 - $15,806	161 Added 10.22%	1,737 $172 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $1,483 - $2,249	23 Added 1.48%	1,576 $120 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $112,017 - $140,158	1,553 New	1,553 $137,000

Others Institutions Holding ABBV

# of Institutions

4,020

Shares Held

1.28B

Call Options Held

18.3M

Put Options Held

13.4M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.

Account

Arkadios Wealth Advisors Abb Vie Inc. Transaction History